- Listed quantity
- 30 sprays
- Supply period
- Not established by spray count
Thirty sprays is a quantity, not a calendar
IVY RX's NAD+ nasal page displays a $179 starting offer alongside a thirty-spray description. That is a more specific package reference than an unexplained bottle image. It is still not a verified thirty-day supply: the number of actuations does not tell the reader how often the product would be prescribed or how much each actuation delivers.
The review keeps those distinctions intact. Bottle volume, concentration, delivered amount and intended supply period should come from the actual prescription and label. We have not inferred a monthly price or calculated a dose from the public spray count. A starting offer can vary with the product and plan ultimately recommended.
Check the route-specific paperwork
This is a nasal prescription listing, presented as an alternative for people who prefer to avoid needles. The public page nevertheless includes references to injection supplies and injection-related testing language. Those passages do not establish what comes with the nasal product and should be clarified before ordering.
Ask for the bottle details, the dispensing pharmacy, directions supplied with that preparation and the refill arrangement. Request an order summary that explicitly names the nasal route. Shared wording across a provider's pages can be a reason to ask a better question without assuming either that the product is defective or that the wording describes a verified nasal kit.
What the service advertises
IVY RX describes online medical review and free delivery, with the possibility of additional contact when the clinician needs clarification. Its same-day review claim concerns the intake process. It does not guarantee approval, arrival of the package or the speed of follow-up once treatment begins.
The public starting offer does not resolve the full ongoing cost. Establish whether the purchase renews, what the next shipment costs, how to stop future orders and whether any assessment charge remains if a prescription is not issued. Those details are especially useful when comparing this thirty-spray listing with another provider's explicitly labeled thirty-day bottle.
Put absorption and benefit claims in context
The page associates NAD+ with energy and mental clarity, while its safety information acknowledges limited evidence for the nasal product's proposed uses. We have not verified a controlled trial of this finished formulation or evidence that its results match an injection or intravenous preparation.
Nasal delivery describes how the product is administered. It does not by itself establish how much reaches the relevant tissues, a dependable onset of benefit or equivalence to another route. FDA's explanation of compounded drugs also makes clear that pharmacy preparation and prescription access should not be confused with drug approval.
Our assessment of the offer
The useful public facts are the named route, starting charge and spray-count description. The most important missing facts concern formulation, duration and renewal. These omissions are manageable comparison questions, but they should remain visible rather than being filled with assumptions that make an attractive monthly figure.
Before committing, obtain a written plan describing what is being prescribed and why, then a matching commercial estimate. If an unexpected reaction or a new symptom occurs, contact an appropriate clinician rather than changing use based on a review. This article evaluates the documentation and purchase terms; it does not establish personal suitability or a treatment schedule.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.